Why Does Melasma Come Back After Laser Treatment? Understanding Relapse and Long-Term Control

CLINICAL GUIDE TO MELASMA

Why Does Melasma Come Back After Laser Treatment?

Laser treatment may lighten existing pigment, but it does not necessarily remove the biological and environmental factors that allow melasma to return.

Written by M.D. Bo Won Lee, Director of Springday Clinic Sinchon, Seoul.

Three-point overview

1. Melasma is a chronic, relapsing pigmentary disorder rather than a single deposit of pigment that can always be permanently removed.

2. Lasers can reduce visible melanin, but ultraviolet radiation, visible light, hormonal influences, inflammation, and altered skin signaling may remain.

3. Sustainable control usually requires accurate diagnosis, photoprotection, appropriate skin care, maintenance treatment, and carefully selected procedures.

Pigment clearance

Laser treatment may reduce melanin that is already present in the skin.

Disease activity

Melanogenic signaling may remain active even when the skin initially appears clearer.

Maintenance

Long-term control matters as much as the initial procedure.

A common scenario is easy to recognize. A patient completes a course of laser toning, sees a noticeable reduction in facial pigmentation, and feels that treatment has worked. Several months later, the patches over the cheeks or forehead gradually become visible again.

This does not automatically mean that the previous treatment was ineffective. It may mean that the laser reduced existing pigment without eliminating the conditions that stimulate new pigment production.

THE CENTRAL POINT

Treating visible melanin is not the same as permanently switching off the tendency to produce melanin.

Melasma is more than excess surface pigment

Melanin is responsible for the visible brown or gray-brown appearance of melasma. However, histological studies indicate that melasma skin may also show abnormalities involving the epidermal barrier, basement membrane zone, upper dermis, mast cells, blood vessels, and photoaging-related structures.

These findings do not mean that every patient has the same pathology or that every abnormality has the same clinical importance. They do support a broader view of melasma as a disorder involving epidermal-dermal interactions rather than pigment alone.

A useful analogy

Removing pigment is like drying a wet floor. If water continues to leak from above, the floor becomes wet again. Laser treatment may remove some of the visible “water,” while light exposure, inflammation, hormonal influences, and altered skin signaling allow pigmentation to return.

What laser treatment can and cannot do

What lasers may help with

• Reducing melanin that is already present
• Improving selected epidermal pigment
• Supporting treatment of resistant melasma
• Targeting different pigment components when properly selected

What lasers do not automatically remove

• Ultraviolet and visible-light exposure
• Genetic susceptibility
• Hormonal influences
• Skin-barrier dysfunction or ongoing irritation
• The lifelong ability of melanocytes to produce pigment

Six reasons melasma may return

1. Light exposure resumes after treatment

Ultraviolet radiation stimulates melanogenesis, but visible light may also contribute to persistent pigmentation, particularly in individuals with more reactive or darker phototypes. Randomized studies have found benefits from photoprotection that addresses short-wavelength visible light in addition to ultraviolet radiation.

2. Melanocytes are still present

Low-fluence laser toning is not intended to eliminate all melanocytes. Pigment may decrease while the cells capable of producing new melanin remain. When they are stimulated again, pigmentation can gradually return.

3. The dermal microenvironment does not change overnight

Basement-membrane alterations, mast-cell activity, vascular changes, and photoaging-related features have been reported in melasma skin. Reducing pigment does not necessarily normalize all of these features after one procedure.

4. The procedure itself may generate inflammation

Excessive fluence, short treatment intervals, and high cumulative energy can irritate the skin. Inflammation may trigger post-inflammatory hyperpigmentation or rebound darkening, particularly in pigment-reactive skin.

5. Hormonal and environmental triggers continue

Pregnancy, hormonal medications, genetic susceptibility, seasonal sun exposure, outdoor activities, and irritating skin-care routines may affect the clinical course. These factors do not affect every patient in the same way.

6. The pigmentation may not be melasma alone

Solar lentigines, freckles, post-inflammatory hyperpigmentation, acquired dermal melanocytosis, and treatment-related hypo- or hyperpigmentation may coexist with melasma. Each component may require a different treatment strategy.

Does stronger treatment produce longer-lasting results?

Not necessarily. A stronger endpoint may create faster visible lightening, but excessive inflammation can worsen melasma or cause post-inflammatory hyperpigmentation.

The opposite assumption is also unsafe. A low-fluence treatment is not automatically harmless when it is repeated too frequently or indefinitely. High cumulative exposure has been associated with mottled hypopigmentation after laser toning.

Reassessment is needed when:

• Redness or burning persists after treatment
• The skin becomes unusually dry and reactive
• Small white macules begin to appear
• Pigmentation becomes more irregular after each session
• Multiple procedures have been performed at short intervals

Initial correction and maintenance are different phases

Initial correction

• Confirm the diagnosis
• Stabilize irritation and barrier dysfunction
• Use appropriate topical therapy
• Select laser or light treatment when indicated
• Establish consistent photoprotection

Maintenance

• Continue realistic daily photoprotection
• Avoid unnecessary irritation
• Use individualized pigment-control products
• Recognize early relapse or adverse effects
• Use procedures intermittently rather than automatically

Who may be considered for laser treatment?

Laser may be considered when

• The diagnosis is reasonably clear
• Photoprotection and topical treatment are insufficient
• The skin is not actively inflamed or severely irritated
• The patient understands the need for maintenance

Treatment may need to be delayed when

• Active dermatitis or persistent burning is present
• Recent tanning or intense sun exposure has occurred
• Mottled hypopigmentation is developing
• Previous procedures caused rebound darkening
• The diagnosis remains uncertain

What I assess in clinical practice

At Springday Clinic Sinchon, treatment planning begins with determining whether the visible pigmentation is entirely melasma or a mixture of melasma and other lesions.

• The distribution and type of pigmentation
• Current erythema, dryness, irritation, and barrier status
• Previous lasers and the skin's response to them
• Outdoor exposure, driving, travel, and sunscreen use
• Whether the treatment goal is realistic and sustainable

Choosing when not to treat can be as important as choosing the laser itself.

Practical checklist for reducing relapse

□ Has the diagnosis been confirmed rather than assuming every brown patch is melasma?

□ Does photoprotection address UVA, UVB, and relevant visible-light exposure?

□ Are hats, shade, and reapplication used during prolonged outdoor exposure?

□ Has persistent redness or burning developed after treatment?

□ Are treatment intervals allowing adequate recovery?

□ Have small white macules or patchy light areas appeared?

□ Are multiple irritating active ingredients being used together?

□ Have pregnancy, hormonal medication, and other medicines been disclosed?

□ Is there a maintenance plan after initial improvement?

Frequently asked questions

Q1. Can laser treatment permanently cure melasma?

No current evidence shows that laser treatment alone can permanently cure melasma. Lasers may reduce visible pigment, but they do not eliminate every biological and environmental trigger. Ongoing photoprotection and maintenance treatment may still be required. Long-term control is a more realistic goal than guaranteed permanent clearance.

Q2. Why did my melasma return several months after laser toning?

New melanin production may have resumed after the existing pigment was reduced. Sun exposure, visible light, hormonal influences, inflammation, and skin irritation may contribute. In some cases, post-inflammatory hyperpigmentation may be mistaken for ordinary relapse. The cause should be reassessed before simply increasing laser energy.

Q3. Is frequent low-fluence laser toning always safe?

No, low fluence does not mean unlimited treatment is risk-free. Short intervals and high cumulative exposure may cause irritation, rebound hyperpigmentation, or mottled hypopigmentation. Treatment should be reassessed if redness, burning, or small pale spots appear. The appropriate interval varies between patients.

Q4. Are picosecond lasers less likely to cause recurrence?

This has not been conclusively established. Picosecond devices use shorter pulses and may emphasize photoacoustic effects, but outcomes still depend on wavelength, fluence, delivery mode, skin type, and treatment history. Long-term comparative recurrence data remain limited. Device selection cannot replace individualized assessment.

Q5. Is sunscreen enough to prevent melasma from returning?

Sunscreen is essential, but it cannot guarantee complete prevention of relapse. Real-world protection depends on the amount applied, reapplication, sweating, friction, and the duration of light exposure. Hats, shade, and other protective measures may also be useful. Existing melasma may require additional treatment.

Q6. Should patients with melasma use tinted sunscreen?

Tinted sunscreen containing pigments such as iron oxides may provide additional visible-light protection. Clinical studies support considering visible-light protection in melasma. However, a product that is uncomfortable or cosmetically unacceptable may not be applied adequately. Consistent use remains important.

Q7. Can melasma and solar lentigines be treated in the same session?

They may sometimes be treated during the same treatment period, but they should not automatically receive identical settings. Solar lentigines are focal lesions, whereas melasma is often diffuse and inflammation-sensitive. Aggressive treatment over melasma-prone skin may cause post-inflammatory darkening. Each pigment component should be identified separately.

Q8. Does hormonally associated melasma respond differently?

Hormonal influences may affect the course of melasma, but the response cannot be predicted from this factor alone. Pregnancy and hormonal medication should be discussed because they may alter treatment options and relapse risk. Medication should not be stopped without consulting the prescribing clinician. An in-person assessment is needed to determine an appropriate plan.

Q9. When should laser treatment be paused?

Treatment should be reassessed when persistent redness, burning, scaling, increased sensitivity, rebound darkening, or small white macules develop. These signs may indicate inflammation, barrier disruption, or pigmentary injury. Continuing the same procedure may worsen the problem. Skin stabilization may be more appropriate than additional energy-based treatment.

Q10. What should I look for when choosing a clinic for melasma treatment?

Look for an assessment that distinguishes melasma from other pigmentary conditions and includes a long-term maintenance strategy. Previous procedures, skin sensitivity, sun exposure, and pigmentary adverse effects should be reviewed. Be cautious about guarantees of permanent clearance after a fixed number of sessions. The clinic should also explain when treatment should be delayed or discontinued.

References

1. Sarkar R, et al. Delphi consensus on melasma management by international experts and Pigmentary Disorders Society. J Eur Acad Dermatol Venereol. 2026;40(4):680-692. doi:10.1111/jdv.70066. PMID:40996222.
2. Chehrara M, et al. The efficacy of laser therapy in melasma treatment: a systematic review and meta-analysis. J Cosmet Dermatol. 2025;24(12):e70602. doi:10.1111/jocd.70602. PMID:41378674.
3. Lee YS, et al. The low-fluence Q-switched Nd:YAG laser treatment for melasma: a systematic review. Medicina. 2022;58(7):936. doi:10.3390/medicina58070936. PMID:35888655.
4. Gao YL, et al. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment. Lasers Med Sci. 2019;34(4):767-771. doi:10.1007/s10103-018-2658-7. PMID:30302596.
5. Espósito ACC, et al. Exploratory study of epidermis, basement membrane zone, upper dermis alterations and Wnt pathway activation in melasma. Ann Dermatol. 2020;32(2):101-108. doi:10.5021/ad.2020.32.2.101. PMID:33911720.
6. Boukari F, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light. J Am Acad Dermatol. 2015;72(1):189-190.e1. doi:10.1016/j.jaad.2014.08.023. PMID:25443629.
7. Castanedo-Cazares JP, et al. Near-visible light and UV photoprotection in the treatment of melasma. Photodermatol Photoimmunol Photomed. 2014;30(1):35-42. doi:10.1111/phpp.12086. PMID:24313385.

Final note

Melasma management should focus on reducing visible pigmentation while minimizing inflammation and slowing relapse. Results may vary, and treatment should be adjusted to skin type, previous procedures, current barrier status, and daily light exposure.

SPRINGDAY CLINIC SINCHON · SEOUL

Recurrent pigmentation should be reassessed before automatically repeating the same laser procedure.

An individualized evaluation can help distinguish ordinary relapse from irritation, post-inflammatory hyperpigmentation, mixed pigmentary disorders, or laser-related hypopigmentation.

 

#Melasma #MelasmaTreatment #MelasmaRecurrence #LaserToning #MelasmaLaser #Hyperpigmentation #VisibleLightProtection #TintedSunscreen #SeoulSkinClinic #SpringdayClinicSinchon

 

다시봄날의원 신촌 서울 서대문구 신촌로 99